114 related articles for article (PubMed ID: 29877614)
1. Population Pharmacokinetic and Exposure-dizziness Modeling for a Metabotropic Glutamate Receptor Subtype 5 Negative Allosteric Modulator in Major Depressive Disorder Patients.
Cosson V; Schaedeli-Stark F; Arab-Alameddine M; Chavanne C; Guerini E; Derks M; Mallalieu NL
Clin Transl Sci; 2018 Sep; 11(5):523-531. PubMed ID: 29877614
[TBL] [Abstract][Full Text] [Related]
2. Basimglurant for treatment of major depressive disorder: a novel negative allosteric modulator of metabotropic glutamate receptor 5.
Fuxe K; Borroto-Escuela DO
Expert Opin Investig Drugs; 2015; 24(9):1247-60. PubMed ID: 26219727
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of basimglurant (RO4917523, RG7090), a unique metabotropic glutamate receptor 5 negative allosteric modulator in clinical development for depression.
Lindemann L; Porter RH; Scharf SH; Kuennecke B; Bruns A; von Kienlin M; Harrison AC; Paehler A; Funk C; Gloge A; Schneider M; Parrott NJ; Polonchuk L; Niederhauser U; Morairty SR; Kilduff TS; Vieira E; Kolczewski S; Wichmann J; Hartung T; Honer M; Borroni E; Moreau JL; Prinssen E; Spooren W; Wettstein JG; Jaeschke G
J Pharmacol Exp Ther; 2015 Apr; 353(1):213-33. PubMed ID: 25665805
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression: A Randomized Clinical Trial.
Quiroz JA; Tamburri P; Deptula D; Banken L; Beyer U; Rabbia M; Parkar N; Fontoura P; Santarelli L
JAMA Psychiatry; 2016 Jul; 73(7):675-84. PubMed ID: 27304433
[TBL] [Abstract][Full Text] [Related]
5. Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results.
Youssef EA; Berry-Kravis E; Czech C; Hagerman RJ; Hessl D; Wong CY; Rabbia M; Deptula D; John A; Kinch R; Drewitt P; Lindemann L; Marcinowski M; Langland R; Horn C; Fontoura P; Santarelli L; Quiroz JA;
Neuropsychopharmacology; 2018 Feb; 43(3):503-512. PubMed ID: 28816242
[TBL] [Abstract][Full Text] [Related]
6. A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [
Guerini E; Schadt S; Greig G; Haas R; Husser C; Zell M; Funk C; Hartung T; Gloge A; Mallalieu NL
Xenobiotica; 2017 Feb; 47(2):144-153. PubMed ID: 27123695
[TBL] [Abstract][Full Text] [Related]
7. Understanding Exposure-Receptor Occupancy Relationships for Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators across a Range of Preclinical and Clinical Studies.
Bennett KA; Sergeev E; MacSweeney CP; Bakker G; Cooper AE
J Pharmacol Exp Ther; 2021 Apr; 377(1):157-168. PubMed ID: 33541889
[TBL] [Abstract][Full Text] [Related]
8. Exploring the Binding Mechanism of Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators in Clinical Trials by Molecular Dynamics Simulations.
Fu T; Zheng G; Tu G; Yang F; Chen Y; Yao X; Li X; Xue W; Zhu F
ACS Chem Neurosci; 2018 Jun; 9(6):1492-1502. PubMed ID: 29522307
[TBL] [Abstract][Full Text] [Related]
9. A Phase 2A Trial of the Novel mGluR5-Negative Allosteric Modulator Dipraglurant for Levodopa-Induced Dyskinesia in Parkinson's Disease.
Tison F; Keywood C; Wakefield M; Durif F; Corvol JC; Eggert K; Lew M; Isaacson S; Bezard E; Poli SM; Goetz CG; Trenkwalder C; Rascol O
Mov Disord; 2016 Sep; 31(9):1373-80. PubMed ID: 27214664
[TBL] [Abstract][Full Text] [Related]
10. Chronic Pharmacological mGluR5 Inhibition Prevents Cognitive Impairment and Reduces Pathogenesis in an Alzheimer Disease Mouse Model.
Hamilton A; Vasefi M; Vander Tuin C; McQuaid RJ; Anisman H; Ferguson SS
Cell Rep; 2016 May; 15(9):1859-65. PubMed ID: 27210751
[TBL] [Abstract][Full Text] [Related]
11. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
Hughes ZA; Neal SJ; Smith DL; Sukoff Rizzo SJ; Pulicicchio CM; Lotarski S; Lu S; Dwyer JM; Brennan J; Olsen M; Bender CN; Kouranova E; Andree TH; Harrison JE; Whiteside GT; Springer D; O'Neil SV; Leonard SK; Schechter LE; Dunlop J; Rosenzweig-Lipson S; Ring RH
Neuropharmacology; 2013 Mar; 66():202-14. PubMed ID: 22551786
[TBL] [Abstract][Full Text] [Related]
12. Population pharmacokinetic analysis of lanicemine (AZD6765), an NMDA channel blocker, in healthy subjects and patients with major depressive disorder.
Agbo F; Bui KH; Zhou D
J Clin Pharm Ther; 2017 Oct; 42(5):539-546. PubMed ID: 28474366
[TBL] [Abstract][Full Text] [Related]
13. DSR-98776, a novel selective mGlu5 receptor negative allosteric modulator with potent antidepressant and antimanic activity.
Kato T; Takata M; Kitaichi M; Kassai M; Inoue M; Ishikawa C; Hirose W; Yoshida K; Shimizu I
Eur J Pharmacol; 2015 Jun; 757():11-20. PubMed ID: 25823809
[TBL] [Abstract][Full Text] [Related]
14. Blocking metabotropic glutamate receptor subtype 5 relieves maladaptive chronic stress consequences.
Peterlik D; Stangl C; Bauer A; Bludau A; Keller J; Grabski D; Killian T; Schmidt D; Zajicek F; Jaeschke G; Lindemann L; Reber SO; Flor PJ; Uschold-Schmidt N
Brain Behav Immun; 2017 Jan; 59():79-92. PubMed ID: 27524668
[TBL] [Abstract][Full Text] [Related]
15. Metabotropic glutamate receptor 5 negative allosteric modulators: discovery of 2-chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl]pyridine (basimglurant, RO4917523), a promising novel medicine for psychiatric diseases.
Jaeschke G; Kolczewski S; Spooren W; Vieira E; Bitter-Stoll N; Boissin P; Borroni E; Büttelmann B; Ceccarelli S; Clemann N; David B; Funk C; Guba W; Harrison A; Hartung T; Honer M; Huwyler J; Kuratli M; Niederhauser U; Pähler A; Peters JU; Petersen A; Prinssen E; Ricci A; Rueher D; Rueher M; Schneider M; Spurr P; Stoll T; Tännler D; Wichmann J; Porter RH; Wettstein JG; Lindemann L
J Med Chem; 2015 Feb; 58(3):1358-71. PubMed ID: 25565255
[TBL] [Abstract][Full Text] [Related]
16. Discovery and Characterization of (R)-6-Neopentyl-2-(pyridin-2-ylmethoxy)-6,7-dihydropyrimido[2,1-c][1,4]oxazin-4(9H)-one (PF-06462894), an Alkyne-Lacking Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator Profiled in both Rat and Nonhuman Primates.
Stepan AF; Claffey MM; Reese MR; Balan G; Barreiro G; Barricklow J; Bohanon MJ; Boscoe BP; Cappon GD; Chenard LK; Cianfrogna J; Chen L; Coffman KJ; Drozda SE; Dunetz JR; Ghosh S; Hou X; Houle C; Karki K; Lazzaro JT; Mancuso JY; Marcek JM; Miller EL; Moen MA; O'Neil S; Sakurada I; Skaddan M; Parikh V; Smith DL; Trapa P; Tuttle JB; Verhoest PR; Walker DP; Won A; Wright AS; Whritenour J; Zasadny K; Zaleska MM; Zhang L; Shaffer CL
J Med Chem; 2017 Sep; 60(18):7764-7780. PubMed ID: 28817277
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, structure-activity relationships and biological evaluation of 4,5,6,7-tetrahydropyrazolopyrazines as metabotropic glutamate receptor 5 negative allosteric modulators.
Hirose W; Kato Y; Yamamoto T; Kassai M; Takata M; Hayashi S; Arai Y; Imai S; Yoshida K
Bioorg Med Chem Lett; 2016 Aug; 26(16):3866-9. PubMed ID: 27432763
[TBL] [Abstract][Full Text] [Related]
18. Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors.
Harvey BD; Siok CJ; Kiss T; Volfson D; Grimwood S; Shaffer CL; Hajós M
Neuropharmacology; 2013 Dec; 75():19-30. PubMed ID: 23831682
[TBL] [Abstract][Full Text] [Related]
19. Imidazo[1,2-a]pyridines: orally active positive allosteric modulators of the metabotropic glutamate 2 receptor.
Trabanco AA; Tresadern G; Macdonald GJ; Vega JA; de Lucas AI; Matesanz E; García A; Linares ML; Alonso de Diego SA; Alonso JM; Oehlrich D; Ahnaou A; Drinkenburg W; Mackie C; Andrés JI; Lavreysen H; Cid JM
J Med Chem; 2012 Mar; 55(6):2688-701. PubMed ID: 22352782
[TBL] [Abstract][Full Text] [Related]
20. CTEP: a novel, potent, long-acting, and orally bioavailable metabotropic glutamate receptor 5 inhibitor.
Lindemann L; Jaeschke G; Michalon A; Vieira E; Honer M; Spooren W; Porter R; Hartung T; Kolczewski S; Büttelmann B; Flament C; Diener C; Fischer C; Gatti S; Prinssen EP; Parrott N; Hoffmann G; Wettstein JG
J Pharmacol Exp Ther; 2011 Nov; 339(2):474-86. PubMed ID: 21849627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
